📰 Given Livanova News
Given Livanova News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Given Livanova. Real-time updates on events, politics, business and more.
May 3, 2024
CellaVision AB (publ) (OTCMKTS:CLVSF – Get Free Report) and LivaNova (NASDAQ:LIVN – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, institutional ownership, dividends, profitability and earnings. Profitability This table compares CellaVision AB (publ) and […]
November 26, 2023
Semler Scientific (NASDAQ:SMLR – Get Free Report) and LivaNova (NASDAQ:LIVN – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, dividends, analyst recommendations, risk, valuation and institutional ownership. Analyst Recommendations This is a breakdown of current recommendations […]
October 20, 2023
Ainos (OTCMKTS:AIMD – Get Free Report) and LivaNova (NASDAQ:LIVN – Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations and dividends. Volatility & Risk Ainos has a beta of 1.07, suggesting […]
May 5, 2023
Endonovo Therapeutics (OTCMKTS:ENDV – Get Rating) and LivaNova (NASDAQ:LIVN – Get Rating) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, risk, analyst recommendations, earnings, valuation, dividends and institutional ownership. Volatility and Risk Endonovo Therapeutics has a beta of 0.25, suggesting […]
May 24, 2022
Yubo International Biotech (OTCMKTS:YBGJ – Get Rating) and LivaNova (NASDAQ:LIVN – Get Rating) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, earnings, valuation and risk. Institutional & Insider Ownership 97.3% of LivaNova shares are held […]